Concomitant suppression of COX-1 and COX-2 is insufficient to induce enteropathy associated with chronic NSAID use
Kayla Barekat, Soumita Ghosh, Christin Herrmann, Karl Keat, Charles‐Antoine Assenmacher, Ceylan Tanes, Naomi Wilson, Ronan Lordan, Antonijo Mrčela, Lubica Rauova, Arjun Sengupta, Ujjalkumar Subhash Das, Robin Joshi, Elliot S. Friedman, Marylyn DeRiggi Ritchie, , Emanuela Ricciotti
The paper shows that suppressing both COX-1 and COX-2 does not cause intestinal injury in mice unless combined with specific NSAIDs, and that gut microbiome changes amplify NSAID-induced enteropathy.
Journal of Clinical Investigation · Jan 27, 2026Peer-reviewedPharmacology & Toxicology